Comparison of High Versus Low Bicarbonate Hemodialysis
Intradialytic Acid-base Changes and Organic Anion Production With High Versus Low Bicarbonate Hemodialysis
1 other identifier
interventional
7
1 country
1
Brief Summary
This study will compare hemodialysis treatment with a standard, high-bicarbonate dialysis bath versus a lower bicarbonate dialysis bath, and will compare intradialytic acid-base changes and overall control of metabolic acidosis with the 2 treatment regimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 24, 2014
CompletedFirst Posted
Study publicly available on registry
March 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJuly 5, 2019
April 1, 2018
1.8 years
March 24, 2014
July 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pre-dialysis serum bicarbonate
Change in predialysis bicarbonate
5 weeks
Secondary Outcomes (6)
serum beta-hydroxybutyrate
5 weeks
beta-hydroxybutyrate clearance
5 weeks
interleukin-6
5 weeks
serum free fatty acids
5 weeks
Time to recover from dialysis
5 weeks
- +1 more secondary outcomes
Study Arms (1)
Low bicarbonate
EXPERIMENTALLow bicarbonate hemodialysis - 30 mEq/L dialysate bicarbonate
Interventions
Eligibility Criteria
You may qualify if:
- Age \>18
- Receiving chronic thrice-weekly conventional hemodialysis for at least 6 months
You may not qualify if:
- Use of oral alkali within the previous month
- Hospitalization within the previous month
- Inability to provide written informed consent
- Plans for kidney transplant in the next 2 months
- Planned change in phosphate binder therapy within the next month
- Pregnancy, or planned pregnancy in the next 2 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Abramowitz, MD, MS
Albert Einstein College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 24, 2014
First Posted
March 28, 2014
Study Start
March 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2016
Last Updated
July 5, 2019
Record last verified: 2018-04